Established in 1991 as Northern Lipids Inc., the company evolved by adding services and expanding its manufacturing capabilities to become TRANSFERRA Nanosciences Inc. TRANSFERRA is a Contract Development and Manufacturing Organization (CDMO) that provides products and services to biotechnology companies engaged in the development of pharmaceutical products.
Serving the needs of companies actively developing lipid nanoparticle drug delivery systems, we work with virtually all classes of pharmaceuticals, from small molecules to peptides, proteins, DNA, mRNA, siRNA and antisense. Our team has made significant contributions to current practices and underlying concepts associated with the formulation of lipid nanoparticle-based pharmaceuticals.
TRANSFERRA offers a range of Chemistry Manufacturing and Controls services:
- small and large-scale LIPEX® equipment for liposome preparation
- lead prototype identification
- manufacturing process development and scale-up
- analytical method development and validation
- clinical trial manufacturing under cGMP
- stability programs
Our extensive North American and International client-base speaks to our value as a strategic partner for companies developing parenteral products for the rational treatment of diseases and conditions.